STI Testing to Enhance PrEP Use in Pregnancy
Trial statusRecruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexFemale
AgeNot listed
SponsorBotswana Harvard AIDS Institute Partnership
About this trial
The investigators are conducting a study in Botswana to see if offering STI testing along with expanded HIV prevention options (PrEP) helps more pregnant women start and continue using PrEP during and after pregnancy. Pregnant women (n=600) seeking antenatal care in Botswana will be enrolled and randomly assigned to receive the standard of care (standard STI assessment with no STI testing) versus STI testing for Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis during pregnancy and postpartum. The investigators' hypothesis is that providing STI testing alongside PrEP offer will encourage more women to start and continue using PrEP.
Eligibility criteria
Qualifiers
Pregnant and seeking antenatal care
Self-identifying as a cis-gender woman
Living without HIV
Not currently using PrEP
Disqualifiers
Male gender
Not pregnant
Living with HIV
Currently using PrEP
Trial design
Treatments tested in this trial
- Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis testing
Treatment groups
600 Participants
are divided into 2 treatment groupsSponsors and collaborators
Botswana Harvard AIDS Institute Partnership
Lead sponsor
University of Washington
Collaborator
University of Botswana
Collaborator
Source ClinicalTrials.gov